Pharmaceutical manufacturer
H.R. 2853 BLOCKING Act of 2021 (All sections of full text). H.R. 5376, Build Back Better Act (All sections of full text). S. 2910, Expanding Access to Low-Cost Generics Act of 2021 (All sections of full text). Discussions regarding S. 3799, PREVENT Pandemics Act of 2022. Discussions regarding the reauthorization of Generic Drug User Fee Amendments. Discussions regarding the approval of generic drugs. Discussions regarding improved education about digital health care. Monitored the implementation of P.L.117-7, To prevent across-the-board direct spending cuts, and for other purposes. Monitored Medicare and prescription drug changes. Monitored discussions related to mental health legislation.
HCR - Health Issues
136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE SMITH-FREE GROUP, LLC
1401 K Street NW Suite 1200, Washington, DC, 20005, US
JACK S DEUSER MICHAEL A. GAFFIN ROBERT HICKMOTT TREVOR W. KOLEGO